DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 9,930.00
-110.00 (-1.10%)
At close: Oct 23, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 182.93 billion as of October 23, 2026. It is the 22,946th most valuable company in the world and the 872nd biggest in South Korea. Its market cap has decreased by 33.23% in one year.
Market Cap
182.93B
Enterprise Value
282.44B
Revenue
148.75B
Global Rank
Country Rank
#872 South Korea
PE Ratio
40.02
ChartMarket Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 182.93B, an increase of 1,067.56%. That is a compound annual growth rate of 11.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 182.93B | -40.08% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 279.23B |
| HEM Pharma | 217.36B |
| GC WellBeing | 202.73B |
| Vivozon Pharmaceutical | 187.11B |
| NOVAREX | 167.21B |
| CellBion | 163.25B |
| Kyung Dong Pharmaceutical | 147.09B |
| HYUNDAI BIOLAND | 134.85B |